David Randall Winn net worth and biography

David Winn Biography and Net Worth

Randall Winn currently serves as managing partner of 22C Capital and is Director of Viteos Fund Services and Merit Software and co-Chairman of Rho AI. Prior to founding 22C Capital, Winn was a co-managing partner and CEO of Capital IQ, a pioneer in the financial intelligence industry, which he managed from 1999 to 2011. Mr. Winn received an A.B. from the Woodrow Wilson School of Public and International Affairs at Princeton University.

What is David Randall Winn's net worth?: The estimated net worth of David Randall Winn is at least $1.33 million as of December 4th, 2020. Mr. Winn owns 83,260 shares of ZoomInfo Technologies stock worth more than $1,333,825 as of May 8th. This net worth estimate does not reflect any other investments that Mr. Winn may own. Learn More about David Randall Winn's net worth.
How do I contact David Randall Winn?: The corporate mailing address for Mr. Winn and other ZoomInfo Technologies executives is 805 BROADWAY ST SUITE 900, VANCOUVER WA, 98660. ZoomInfo Technologies can also be reached via phone at 800-914-1220 and via email at [email protected]. Learn More on David Randall Winn's contact information.
Has David Randall Winn been buying or selling shares of ZoomInfo Technologies?: David Randall Winn has not been actively trading shares of ZoomInfo Technologies during the last quarter. Most recently, David Randall Winn sold 60,682 shares of the business's stock in a transaction on Monday, September 13th. The shares were sold at an average price of $64.81, for a transaction totalling $3,932,800.42. Learn More on David Randall Winn's trading history.
Who are ZoomInfo Technologies' active insiders?: ZoomInfo Technologies' insider roster includes Kirk Brown (COO), Todd Crockett (Director), Eric Edell (Major Shareholder), Keith Enright (Director), Joseph Hays (COO), Peter Hyzer (CFO), Nir Keren (Insider), Mark Mader (Director), Jason Mironov (Director), Henry Schuck (CEO), and David Winn (Director). Learn More on ZoomInfo Technologies' active insiders.
Are insiders buying or selling shares of ZoomInfo Technologies?: In the last year, insiders at the sold shares 7 times. They sold a total of 2,096,984 shares worth more than $55,385,195.62. The most recent insider tranaction occured on December, 4th when CTO Ali Dasdan sold 5,007 shares worth more than $73,552.83. Insiders at ZoomInfo Technologies own 8.2% of the company. Learn More about insider trades at ZoomInfo Technologies.
Information on this page was last updated on 12/4/2023.

David Randall Winn Insider Trading History at ZoomInfo Technologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/13/2021	Sell	60,682	$64.81	$3,932,800.42
9/2/2021	Sell	15,404	$62.00	$955,048.00
8/11/2021	Sell	102,690	$62.00	$6,366,780.00
8/6/2021	Sell	132,598	$54.75	$7,259,740.50
8/2/2021	Sell	21,434	$55.02	$1,179,298.68
12/4/2020	Sell	83,260	$43.88	$3,653,448.80	83,260

David Randall Winn Buying and Selling Activity at ZoomInfo Technologies

ZoomInfo Technologies Company Overview

ZoomInfo Technologies Inc., together with its subsidiaries, provides go-to-market intelligence and engagement platform for sales and marketing teams in the United States and internationally. The company's cloud-based platform provides information on organizations and professionals to help users identify target customers and decision makers, obtain continually updated predictive lead and company scoring, monitor buying signals and other attributes of target companies, craft messages, engage through automated sales tools, and track progress through the deal cycle. It serves enterprises, mid-market companies, and down to small businesses that operate in various industry, including software, business services, manufacturing, telecommunications, financial services, media and internet, transportation, education, hospitality, and real estate. The company was founded in 2007 and is headquartered in Vancouver, Washington.

Today's Range

Now: $12.15

$11.67

$13.07

50 Day Range

MA: $16.04

$15.08

$17.29

2 Week Range

Now: $12.15

$11.67

$30.16

Volume

22,567,780 shs

Average Volume

6,448,618 shs

Market Capitalization

$4.61 billion

P/E Ratio

45.00

Dividend Yield

N/A

Beta

1.13

Fidelity, Bezos, Goldman Bet Big on Tiny Biotech

From Behind the Markets | Ad

Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.

Don't miss out on the "next Ozempic" >>>